Real-time enrollment status for this borderline-resectable pancreatic cancer clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 8:07 PM UTC
| NCT Number | NCT06173310 |
| Recruiting Status | Recruiting |
| Condition | Borderline-resectable Pancreatic Cancer |
| Phase | NA |
| Target Enrollment | 50 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Ohio State University |
| Last Updated on CT.gov | February 27, 2026 (Feb 27, 2026) |
As of July 18, 2026: Clinical trial NCT06173310 is currently recruiting participants. This na study for borderline-resectable pancreatic cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by Ohio State University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06173310 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06173310 was last updated Feb 27, 2026 (February 27, 2026). HelloStudys verifies this status automatically.